Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Internet-based chronic disease management and hydrochlorothiazide use in adults with primary hypertension
ChiCTR-IPR-17013413Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydrochlorothiazide in essential hypertension (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: blood pressure, all-cause mortality and 7 more. Planned start Dec 2017; status: not yet recruiting.
02
Drugs
hydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-IPR-17013413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013413.